Please ensure Javascript is enabled for purposes of website accessibility

Cigna and Humana Join Aetna in Waiving COVID-19 Patients' Cost-Sharing Payments

By Brian Orelli, PhD - Mar 30, 2020 at 2:01PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The insurers could benefit from the move.

Heath insurers Cigna (CI) and Humana (HUM 0.03%) are waiving co-payments and cost-sharing for patients with COVID-19, the disease caused by the new coronavirus. CVS Health's (CVS -1.22%) Aetna insurance group announced a similar policy last week.

"It's a lot of money they're waiving," President Donald Trump said of Cigna and Humana at a press conference on Sunday where the announcement was made. Apparently, it doesn't pay to be first because there was no mention of Aetna during the press conference.

The companies will also not require co-pays for COVID-19 testing. That was made mandatory by the $2 trillion CARES Act passed last week, but many insurers had already announced they were waiving costs for testing.

Doctor in a face mask listening to a face-masked patient's heart

Image source: Getty Images.

The new COVID-19 policies will give Cigna, Humana, and CVS Health some positive publicity, but the moves could also end up saving companies money, too. If patients delay testing or treatment because they're worried about how much it will cost them -- a real possibility given the number of people who have recently lost their job -- their illnesses could progress further than they might have if they had gotten medical care earlier, resulting in higher costs for the insurers.

CVS Health and Humana have also waived co-payments for telehealth consultations for any medical issues during the COVID-19 outbreak. The policies could have a double benefit for the insurers: They'll keep patients out of doctors' offices, reducing their risk of exposure to COVID-19, and also introduce patients to telehealth, which costs insurers less to provide. More people becoming familiar with telehealth could lead to more of them continuing to use it, even after the pandemic has ended.

Brian Orelli has no position in any of the stocks mentioned. The Motley Fool recommends CVS Health. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Humana Inc. Stock Quote
Humana Inc.
HUM
$495.89 (0.03%) $0.17
Cigna Corporation Stock Quote
Cigna Corporation
CI
CVS Health Corporation Stock Quote
CVS Health Corporation
CVS
$103.64 (-1.22%) $-1.28

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
394%
 
S&P 500 Returns
127%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/18/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.